Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Anti-tumor necrosis factor α treatment of interferon-α-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation.

Bethunaickan R, Sahu R, Liu Z, Tang YT, Huang W, Edegbe O, Tao H, Ramanujam M, Madaio MP, Davidson A.

Arthritis Rheum. 2012 Oct;64(10):3399-408. doi: 10.1002/art.34553.

2.

CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.

Moser K, Kalies K, Szyska M, Humrich JY, Amann K, Manz RA.

Arthritis Rheum. 2012 Apr;64(4):1237-46. doi: 10.1002/art.33424. Epub 2011 Oct 17.

3.

Laquinimod delays and suppresses nephritis in lupus-prone mice and affects both myeloid and lymphoid immune cells.

Lourenço EV, Wong M, Hahn BH, Palma-Diaz MF, Skaggs BJ.

Arthritis Rheumatol. 2014 Mar;66(3):674-85. doi: 10.1002/art.38259.

4.

Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.

Summers SA, Odobasic D, Khouri MB, Steinmetz OM, Yang Y, Holdsworth SR, Kitching AR.

Clin Exp Immunol. 2014 Jun;176(3):341-50. doi: 10.1111/cei.12287.

5.

Bcl-2 as a Therapeutic Target in Human Tubulointerstitial Inflammation.

Ko K, Wang J, Perper S, Jiang Y, Yanez D, Kaverina N, Ai J, Liarski VM, Chang A, Peng Y, Lan L, Westmoreland S, Olson L, Giger ML, Chun Wang L, Clark MR.

Arthritis Rheumatol. 2016 Nov;68(11):2740-2751. doi: 10.1002/art.39744.

6.

Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.

Kalaaji M, Sturfelt G, Mjelle JE, Nossent H, Rekvig OP.

Arthritis Rheum. 2006 Mar;54(3):914-26.

7.

A unique hybrid renal mononuclear phagocyte activation phenotype in murine systemic lupus erythematosus nephritis.

Bethunaickan R, Berthier CC, Ramanujam M, Sahu R, Zhang W, Sun Y, Bottinger EP, Ivashkiv L, Kretzler M, Davidson A.

J Immunol. 2011 Apr 15;186(8):4994-5003. doi: 10.4049/jimmunol.1003010. Epub 2011 Mar 16.

8.

Interferon-α accelerates murine systemic lupus erythematosus in a T cell-dependent manner.

Liu Z, Bethunaickan R, Huang W, Lodhi U, Solano I, Madaio MP, Davidson A.

Arthritis Rheum. 2011 Jan;63(1):219-29. doi: 10.1002/art.30087.

9.

Selective HDAC6 inhibition decreases early stage of lupus nephritis by down-regulating both innate and adaptive immune responses.

Ren J, Liao X, Vieson MD, Chen M, Scott R, Kazmierczak J, Luo XM, Reilly CM.

Clin Exp Immunol. 2018 Jan;191(1):19-31. doi: 10.1111/cei.13046. Epub 2017 Oct 16.

PMID:
28876451
10.

Macrophage depletion ameliorates nephritis induced by pathogenic antibodies.

Chalmers SA, Chitu V, Herlitz LC, Sahu R, Stanley ER, Putterman C.

J Autoimmun. 2015 Feb;57:42-52. doi: 10.1016/j.jaut.2014.11.007. Epub 2014 Dec 29.

11.

Suppression of glomerulonephritis in lupus-prone NZB × NZW mice by RN486, a selective inhibitor of Bruton's tyrosine kinase.

Mina-Osorio P, LaStant J, Keirstead N, Whittard T, Ayala J, Stefanova S, Garrido R, Dimaano N, Hilton H, Giron M, Lau KY, Hang J, Postelnek J, Kim Y, Min S, Patel A, Woods J, Ramanujam M, DeMartino J, Narula S, Xu D.

Arthritis Rheum. 2013 Sep;65(9):2380-91. doi: 10.1002/art.38047.

12.

A dexamethasone prodrug reduces the renal macrophage response and provides enhanced resolution of established murine lupus nephritis.

Yuan F, Tabor DE, Nelson RK, Yuan H, Zhang Y, Nuxoll J, Bynoté KK, Lele SM, Wang D, Gould KA.

PLoS One. 2013 Nov 28;8(11):e81483. doi: 10.1371/journal.pone.0081483. eCollection 2013.

13.

Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis.

Kanapathippillai P, Hedberg A, Fenton CG, Fenton KA.

Cytokine. 2013 May;62(2):244-52. doi: 10.1016/j.cyto.2013.03.016. Epub 2013 Apr 4.

PMID:
23561928
14.

Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.

Pau E, Chang NH, Loh C, Lajoie G, Wither JE.

Clin Immunol. 2011 May;139(2):215-27. doi: 10.1016/j.clim.2011.02.005. Epub 2011 Mar 17.

PMID:
21414847
15.

Bortezomib treatment prevents glomerulosclerosis associated with lupus nephritis in a murine model through suppressive effects on the immune and renin-angiotensin systems.

Matsuki-Muramoto Y, Nozawa K, Uomori K, Sekigawa I, Takasaki Y.

Mod Rheumatol. 2017 Jan;27(1):77-86. doi: 10.3109/14397595.2016.1170957. Epub 2016 May 11.

PMID:
27166507
16.

Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.

Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, Madaio MP, Bottinger EP, Davidson A.

J Immunol. 2008 Feb 1;180(3):1938-47. Erratum in: J Immunol. 2008 Mar 1;180(5):3613. Madaio, Michael M [corrected to Madaio, Michael P].

17.

Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB/W F1 mice by a mechanism downstream of renal immune complex deposition.

Schiffer L, Sinha J, Wang X, Huang W, von Gersdorff G, Schiffer M, Madaio MP, Davidson A.

J Immunol. 2003 Jul 1;171(1):489-97. Erratum in: J Immunol. 2003 Aug 1;171(3):1610. Von Gonsdorff Gero [corrected to von Gersdorff Gero].

18.

Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis.

Quezada SA, Eckert M, Adeyi OA, Schned AR, Noelle RJ, Burns CM.

Arthritis Rheum. 2003 Sep;48(9):2541-54.

19.

Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.

Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.

FASEB J. 2004 Mar;18(3):534-6. Epub 2004 Jan 20.

PMID:
14734643
20.

Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.

Savarese E, Steinberg C, Pawar RD, Reindl W, Akira S, Anders HJ, Krug A.

Arthritis Rheum. 2008 Apr;58(4):1107-15. doi: 10.1002/art.23407.

Supplemental Content

Support Center